Interferon regulatory factor 1 (IRF-1) and IRF-2 expression in breast cancer tissue microarrays

Journal of Interferon and Cytokine Research

Volumn 25, Issue 10, 2005, Pages 587-594

  Connett, Judith M ^a   Badri, Linda ^a   Giordano, Thomas J ^a   Connett, William C ^b   Doherty, Gerard M ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MISSOURI ST LOUIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERFERON REGULATORY FACTOR 1; INTERFERON REGULATORY FACTOR 2;

ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER INHIBITION; CANCER INVASION; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TISSUE MICROARRAY; TUMOR IMMUNITY;

BREAST NEOPLASMS; CARCINOMA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERFERON REGULATORY FACTOR-1; INTERFERON REGULATORY FACTOR-2; INTERFERON TYPE II; SIGNAL TRANSDUCTION; TISSUE ARRAY ANALYSIS; TUMOR ESCAPE;

ANIMALIA;

EID: 27144450666     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.2005.25.587     Document Type: Article

References (31)

1. Walker PR, Saas P, Dietrich PY. Role of Fas ligand (CD95L) in immune escape: the tumor cell strikes back. J. Immunol. 1997;158:4521-4524.
2. Doherty GM, McCluskey B, Tsung K, Norton JA. Correlation of Interferon regulatory factors 1 and 2 (IRF-1 and -2): expression and murine tumor growth in the presence of interferon-gamma. Surg. Forum 1995;46:544-546.
3. Doherty GM, Alexander HR, Merino MJ, Venzon DJ, Norton JA. Role of endogenous interferon gamma in murine tumor growth and tumor necrosis factor alpha antitumor efficacy. Ann. Surg. Oncol. 1996;3:198-203.
4. Yim JH, Wu S, Vander Velde TL, Norton JA, Doherty GM. Interferon regulatory factor-2 gene transfer into murine melanoma enhances tumorigenicity and resistance to interferon-γ and tumor necrosis factor-α. Proc. Am. Assoc. Cancer Res. 1997;38:96.
5. Fujita T, Reis LF, Watanabe N, Kimura Y, Taniguchi T, Vilcek J. Induction of the transcription factor IRF-1 and interferon-beta mRNAs by cytokines and activators of second-messenger pathways. Proc. Natl. Acad. Sci. USA 1989;86:9936-9940.
6. Geller DA, Nguyen D, Shapiro RA, Nussler A, Di Silvio M, Freeswick P, Wang SC, Tweardy DJ, Simmons RL, Billiar TR. Cytokine induction of interferon regulatory factor-1 in hepatocytes. Surgery 1993;114:235-242.
7. Harroch S, Revel M, Chebath J. Induction by interleukin-6 of interferon regulatory factor 1 (IRF-1) gene expression through the palindromic interferon response element pIRE and cell type-dependent control of IRF-1 binding to DNA. EMBO J. 1994;13:1942-1949.
8. Martin E, Nathan C, Xie Q-W. Role of interferon regulatory factor 1 in induction of nitric oxide synthase. J. Exp. Med. 1994; 180:977-984.
9. Briken V, Ruffner H, Schultz U, Schwarz A, Reis LFL, Strehlow I, Decker T, Staeheli P. Interferon regulatory factor 1 is required for mouse Gbp gene activation by gamma interferon. Mol. Cell. Biol. 1995;15:975-982.
10. Taniguchi T, Ogasawara K, Takaoka A, Tanaka N. IRF family of transcription factors as regulators of host defense. Annu. Rev. Immunol. 2001;19:623-655.
11. Chang C-H, Hammer J, Loh JE, Fodor WL, Flavell RA. The activation of major histocompatibility complex class I genes by interferon regulatory factor-1 (IRF-1). Immunogenetics 1992;35:378-384.
12. Reis LFL, Harada H, Wolchok JD, Taniguchi T, Vilcek J. Critical role of a common transcription factor, IRF-1, in the regulation of IFN-beta and IFN-inducible genes. EMBO J. 1992;11:185-193.
13. Sok-Pin Tan R, Taniguchi T, Harada H. Identification of the lysyl oxidase gene as a target of the antioncogenic transcription factor, IRF-1, and its possible role in tumor suppression. Cancer Res. 1996;56:2417-2421.
14. Harada H, Kitagawa M, Tanaka N, Yamamoto H, Harada K, Ishihara M, Taniguchi T. Anti-oncogenic and oncogenic potentials of interferon regulatory factors-1 and -2. Science 1993;259:971-974.
15. Fujita T, Kimura Y, Miyamoto M, Barsoumian EL, Taniguchi T. Induction of endogenous IFN-alpha and IFN-beta genes by a regulatory transcription factor, IRF-1. Nature 1989;337:270-272.
16. Tanaka N, Kawakami T, Taniguchi T. Recognition DNA sequences of interferon regulatory factor 1 (IRF-1) and IRF-2, regulators of cell growth and the interferon system. Mol. Cell. Biol. 1993;13:4531-4538.
17. Connett JM, Hunt SR, Hickerson SM, Wu S, Doherty GM. Localization of IFN-γ-gamma-activated Stall and interferon regulatory factors 1 and 2 in breast cancer cells. J. Interferon Cytokine Res. 2003;23:621-630.
18. Lowney JK, Boucher LD, Swanson PE, Doherty GM. Interferon regulatory factor-1 and -2 expression in human melanoma specimens. Ann. Surg. Oncol. 1999;6:604-608.
19. Doherty GM, Boucher L, Sorenson K, Lowney J. Interferon regulatory factor expression in human breast cancer. Ann. Surg. 2001;233:623-629.
20. Nocito A, Bubendorf L, Maria Tinner E, Suess K, Wagner U, Forster T, Kononen J, Fijan A, Bruderer J, Schmid U, Ackermann D, Maurer R, Alund G, Knonagel H, Rist M, Anabitarte M, Hering F, Hardmeier T, Schoenenberger AJ, Flury R, Jager P, Luc Fehr J, Schraml P, Moch H, Mihatsch MJ, Gasser T, Sauter G. Microarrays of bladder cancer tissue are highly representative of proliferation index and histological grade. J Pathol. 2001;194:349-357.
21. Schraml P, Kononen J, Bubendorf L, Moch H, Bissig H, Nocito A, Mihatsch MJ, Kallioniemi OP, Sauter G. Tissue microarrays for gene amplification surveys in many different tumor types. Clin. Cancer Res. 1999;5:1966-1975.
22. Richter J, Wagner U, Kononen J, Fijan A, Bruderer J, Schmid U, Ackermann D, Maurer R, Alund G, Knonagel H, Rist M, Wilber K, Anabitarte M, Hering F, Hardmeier T, Schonenberger A, Flury R, Jager P, Fehr JL, Schraml P, Moch H, Mihatsch MJ, Gasser T, Kallioniemi OP, Sauter G. High-throughput tissue microarray analysis of cyclin E gene amplification and overexpression in urinary bladder cancer. Am. J. Pathol. 2000; 157:787-794.
23. Callagy G, Cattaneo E, Daigo Y, Happerfield L, Bobrow LG, Pharoah PD, Caldas C. Molecular classification of breast carcinomas using tissue microarrays. Diagn. Mol. Pathol. 2003;12:27-34.
24. Yim JH, Connett JM, Ro SH, Lowney JK, Wu SJ, Doherty GM. The role of interferon regulatory factor-1 and interferon regulatory factor-2 in IFN-γ growth inhibition of human breast carcinoma cell lines. J. Interferon Cytokine Res. 2003;23:501-511.
25. Yim J, Ro SH, Lowney JK, Wu SJ, Connett J, Doherty GM. The role of interferon regulatory factor-1 and interferon regulatory factor-2 in IFN-γ growth inhibition of human breast carcinoma cell lines. J. Interferon Cytokine Res. 2003;23:501-511.
26. Kuroboshi H, Okubo T, Kitaya K, Nakayama T, Daikoku N, Fushiki S, Honjo H. Interferon regulatory factor-1 expression in human uterine endometrial carcinoma. Gynecol. Oncol. 2003; 91354-358.
27. Coccia EM, Del Russo N, Stellacci E, Orsatti R, Benedetti E, Marziali G, Hiscott J, Battistini A. Activation and repression of the 2-5A synthetase and p21 gene promoters by IRF-1 and IRF-2. Oncogene 1999;18:2129-2137.
28. Masumi A, Ozato K. Coactivator p300 acetylates the interferon regulatory factor-2 in U937 cells following phorbol ester treatment. J. Biol. Chem. 2001;276:20973-20980.
29. Masumi A, Yamakawa Y, Fukazawa H, Ozato K, Komuro K. Interferon regulatory factor-2 regulates cell growth through its acetylation. J. Biol. Chem. 2003;278:25401-25407.
30. Pine R, Decker T, Kessler DS, Levy DE, Darnell JE, Jr. Purification and cloning of interferon-stimulated gene factor 2 (ISGF2): ISGF2 (IRF-1) can bind to the promoters of both beta interferon-and interferon-stimulated genes but is not a primary transcriptional activator of either. Mol. Cell. Biol. 1990; 10:2448-2457.
31. Watanabe N, Sakakibara J, Hovanessian AG, Taniguchi T, Fujita T. Activation of IFN-beta element by IRF-1 requires a post-translational event in addition to IRF-1 synthesis. Nucleic Acids Res. 1991;19:4421-4428.